Stay updated on TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial

Sign up to get notified when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” It is unrelated to the clinical trial record.
    Difference
    0.6%
    Check dated 2026-10-25T01:56:14.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:45:12.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:18:58.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study record history gains a new Revision: v3.7.0 entry and removes the prior Revision: v3.6.6 from the list, reflecting a metadata update to the record.
    Difference
    0.1%
    Check dated 2026-09-20T01:02:46.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.6.6, replacing Revision: v3.6.5, indicating an update to the page's revision metadata.
    Difference
    0.1%
    Check dated 2026-08-29T18:57:46.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.5 replacing v3.6.4. This reflects a small update to the page's revision labeling or underlying UI/backend.
    Difference
    0.1%
    Check dated 2026-08-08T09:56:33.000Z thumbnail image

Stay in the know with updates to TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TACTI-002: IMP321 Combo Study NSCLC HNSCC Clinical Trial page.